RESUMEN
Malnutrition continues to affect the growth and development of millions of children worldwide, and chronic undernutrition has proven to be largely refractory to interventions. Improved understanding of metabolic development in infancy and how it differs in growth-constrained children may provide insights to inform more timely, targeted, and effective interventions. Here, the metabolome of healthy infants was compared to that of growth-constrained infants from three continents over the first 2 years of life to identify metabolic signatures of aging. Predictive models demonstrated that growth-constrained children lag in their metabolic maturity relative to their healthier peers and that metabolic maturity can predict growth 6 months into the future. Our results provide a metabolic framework from which future nutritional programs may be more precisely constructed and evaluated.
Asunto(s)
Desarrollo Infantil , Metabolismo Energético , Factores de Edad , Biomarcadores , Trastornos de la Nutrición del Niño/epidemiología , Trastornos de la Nutrición del Niño/metabolismo , Preescolar , Países en Desarrollo , Femenino , Humanos , Lactante , Masculino , Desnutrición/epidemiología , Desnutrición/etiología , Desnutrición/metabolismo , Metaboloma , Metabolómica/métodosRESUMEN
Improving understanding of the pathogen-specific seasonality of enteric infections is critical to informing policy on the timing of preventive measures and to forecast trends in the burden of diarrhoeal disease. Data obtained from active surveillance of cohorts can capture the underlying infection status as transmission occurs in the community. The purpose of this study was to characterise rotavirus seasonality in eight different locations while adjusting for age, calendar time and within-subject clustering of episodes by applying an adapted Serfling model approach to data from a multi-site cohort study. In the Bangladesh and Peru sites, within-subject clustering was high, with more than half of infants who experienced one rotavirus infection going on to experience a second and more than 20% experiencing a third. In the five sites that are in countries that had not introduced the rotavirus vaccine, the model predicted a primary peak in prevalence during the dry season and, in three of these, a secondary peak during the rainy season. The patterns predicted by this approach are broadly congruent with several emerging hypotheses about rotavirus transmission and are consistent for both symptomatic and asymptomatic rotavirus episodes. These findings have practical implications for programme design, but caution should be exercised in deriving inferences about the underlying pathways driving these trends, particularly when extending the approach to other pathogens.
Asunto(s)
Análisis por Conglomerados , Transmisión de Enfermedad Infecciosa , Infecciones por Rotavirus/epidemiología , Estaciones del Año , África/epidemiología , Asia/epidemiología , Preescolar , Estudios de Cohortes , Humanos , Lactante , Recién Nacido , Prevalencia , Infecciones por Rotavirus/transmisión , América del Sur/epidemiologíaRESUMEN
Environmental enteropathy (EE) is a syndrome of altered small intestine structure and function hypothesized to be common among individuals lacking access to improved water and sanitation. There are plausible biological mechanisms, both inflammatory and non-inflammatory, by which EE may alter the cardiometabolic profile. Here, we test the hypothesis that EE is associated with the cardiometabolic profile among young children living in an environment of intense enteropathogen exposure. In total, 156 children participating in the Peruvian cohort of a multicenter study on childhood infectious diseases, growth and development were contacted at 3-5 years of age. The urinary lactulose:mannitol ratio, and plasma antibody to endotoxin core were determined in order to assess intestinal permeability and bacterial translocation. Blood pressure, anthropometry, fasting plasma glucose, insulin, and cholesterol and apolipoprotein profiles were also assessed. Extant cohort data were also used to relate biomarkers of EE during the first 18 months of life to early child cardiometabolic profile. Lower intestinal surface area, as assessed by percent mannitol excretion, was associated with lower apolipoprotein-AI and lower high-density lipoprotein concentrations. Lower intestinal surface area was also associated with greater blood pressure. Inflammation at 7 months of age was associated with higher blood pressure in later childhood. This study supports the potential for a relationship between EE and the cardiometabolic profile.
Asunto(s)
Enfermedades Cardiovasculares/epidemiología , Exposición a Riesgos Ambientales/efectos adversos , Enfermedades Intestinales/epidemiología , Intestino Delgado , Enfermedades Metabólicas/epidemiología , Enfermedades Cardiovasculares/diagnóstico , Enfermedades Cardiovasculares/metabolismo , Preescolar , Estudios de Cohortes , Femenino , Humanos , Enfermedades Intestinales/diagnóstico , Enfermedades Intestinales/metabolismo , Intestino Delgado/metabolismo , Intestino Delgado/patología , Estudios Longitudinales , Masculino , Enfermedades Metabólicas/diagnóstico , Enfermedades Metabólicas/metabolismo , Perú/epidemiología , Estudios Prospectivos , Factores de RiesgoRESUMEN
BACKGROUND: Environmental enteric dysfunction (EED) is an asymptomatic intestinal disorder affecting populations living in conditions of poor sanitation and hygiene. The study tested intestinal barrier function in infants with EED. METHODS: We prospectively studied an advanced high-performance liquid chromatography mass spectrometry assay of urine collected after oral intake of the monosaccharide, L-rhamnose and the disaccharide, lactulose, in 112 children from three continents. FINDINGS: Compared to the US cohort (n=27), the cohorts of children from Peru (n=19) and Zambia (n=85) were older with evidence of growth impairment. The median (range) of age (months) was 8.0 (2.0 to 13.0), 27.0 (15.0 to 29.0) and 21.0 (12.0 to 36.0), respectively. The median (range) of height for age Z score was -0.1 (-1.8 to 2.4), -1.8 (-3.3 to -0.2) and -2.3 (-8.5 to 1.2), respectively. Among children with valid sugar data (n=22 USA, n=19 Peru, n=73 Zambia), there were no significant differences in the median rhamnose urine concentrations between the three groups. The median (range) lactulose concentration (µg/mL) was 6.78 (0.29 to 31.90), 47.60 (4.23 to 379.00) and 75.40 (0.67 to 873.00) in the US, Peruvian and Zambian cohorts, respectively (p<0.001). The lactulose/rhamnose ratio (LRR) was higher in cohorts from Peru (0.75, 0.15, 5.02) and Zambia (2.26, 0.08, 14.48) compared to the US (0.14, 0.06, 1.00) cohort (p<0.001). In a multivariate effect modification model, higher weight-for-age z scores were associated with lower post-dose lactulose when rhamnose excretion was constant (p=0.003). CONCLUSIONS: This non-invasive two saccharide permeability protocol measures changes in intestinal permeability in children with EED and permits the identification of individuals for interventional trials.
RESUMEN
OBJECTIVE: To describe fetal macrocrania including prenatal diagnosis, delivery considerations and clinical outcomes. STUDY DESIGN: A retrospective case series was developed by reviewing 26 885 ultrasounds performed between 1 March 2003 and 30 June 2007 for the prenatal diagnosis of macrocrania. Medical records of each mother/infant pair were reviewed for demographic information, ultrasound findings, obstetric management and outcomes. RESULT: Twenty-three fetuses were diagnosed with macrocrania. Median gestational age at diagnosis was 31.1 weeks (range 18.3-38.1) and at delivery was 36.9 weeks (range 30.7-39.9). Fifteen patients (65%) underwent amniocentesis for karyotype; none were aneuploid but one had a duplication on chromosome 7. All the 23 infants were liveborn. Twenty-one deliveries were by Cesarean (91%), with thirteen of these by classical incision (62%). Of the infants, 5 (22%) died shortly after birth, 16 (70%) were stabilized in the neonatal intensive care unit and were discharged alive and 2 (8%) were transferred to another center and subsequently died. Eighteen babies required ventriculoperitoneal shunting (78%). CONCLUSION: Macrocrania is a diagnosis usually made in children but can also be made prenatally. Fetal macrocrania is usually a result of ventriculomegaly due to an obstructive process to cerebrospinal fluid flow. Abdominal delivery is usually required, often necessitating a classical uterine incision. Targeted ultrasonography, extensive counseling of parents and delivery at a tertiary care center with availability of neurosurgery is recommended.
Asunto(s)
Cesárea , Enfermedades Fetales/diagnóstico por imagen , Cráneo/anomalías , Cráneo/diagnóstico por imagen , Ultrasonografía Prenatal , Centros Médicos Académicos , Adolescente , Adulto , Amniocentesis , Estudios de Cohortes , Femenino , Edad Gestacional , Humanos , Hidrocefalia/diagnóstico por imagen , Hidrocefalia/cirugía , Recién Nacido , Embarazo , Resultado del Embarazo , Estudios Retrospectivos , Análisis de Supervivencia , Derivación Ventriculoperitoneal , Adulto JovenRESUMEN
A patient with hypoplastic left ventricle and double outlet right ventricle underwent pulmonary artery band as a newborn. At age 3 months, cardiac catheterization demonstrated complete closure of his atrial septal defect with decompression of the left atrium via a small levo-cardinal vein. Thus, he had normally connected, anomalously draining obstructed pulmonary veins. He underwent successful catheter intervention with excellent release of the obstruction. This rare finding and technical aspects of catheter intervention are discussed.
Asunto(s)
Cateterismo Cardíaco/métodos , Ventrículo Derecho con Doble Salida/terapia , Ventrículos Cardíacos/anomalías , Válvula Mitral/anomalías , Anomalías Múltiples/diagnóstico , Anomalías Múltiples/cirugía , Ventrículo Derecho con Doble Salida/diagnóstico , Estudios de Seguimiento , Cardiopatías Congénitas/diagnóstico , Cardiopatías Congénitas/cirugía , Hemodinámica/fisiología , Humanos , Lactante , Masculino , Venas Pulmonares/fisiopatología , Medición de Riesgo , Resultado del TratamientoAsunto(s)
ADP Ribosa Transferasas , Toxinas Bacterianas , Polisacáridos Bacterianos , Fiebre Tifoidea/prevención & control , Vacunas Tifoides-Paratifoides , Factores de Virulencia , Exotoxinas , Humanos , Polisacáridos Bacterianos/efectos adversos , Polisacáridos Bacterianos/inmunología , Fiebre Tifoidea/inmunología , Vacunas Tifoides-Paratifoides/efectos adversos , Vacunas Tifoides-Paratifoides/inmunología , Vacunas Conjugadas/efectos adversos , Vacunas Conjugadas/inmunología , Exotoxina A de Pseudomonas aeruginosaRESUMEN
Cryptosporidiosis was recognised in human beings in 1976, and was prominent in the 1980s and 1990s as a cause of severe diarrhoeal illness in patients with AIDS. It is now additionally recognised as a major cause of waterborne diarrhoeal illness in developed regions, and as a pathogen with long-term effect on childhood growth and development in impoverished areas. This update focuses on recent changes in our understanding of the taxonomy of cryptosporidium, its epidemiology, effects, pathogenesis, diagnosis, and treatment.
Asunto(s)
Criptosporidiosis/epidemiología , Cryptosporidium/clasificación , Estadios del Ciclo de Vida/fisiología , Animales , Criptosporidiosis/diagnóstico , Criptosporidiosis/patología , Criptosporidiosis/terapia , Cryptosporidium/crecimiento & desarrollo , Cryptosporidium/inmunología , Diarrea/epidemiología , Diarrea/parasitología , Humanos , Huésped Inmunocomprometido , Filogenia , Abastecimiento de Agua/normasRESUMEN
An investigation was performed after an outbreak of bartonellosis in a region of Peru nonendemic for this disorder. Symptoms of acute and chronic bartonellosis were recorded. Serological analysis was performed on 55% of the affected population (554 individuals), 77.5% of whom demonstrated previous infection with Bartonella bacilliformis. The attack rate of Oroya fever was 13.8% (123 cases); the case-fatality rate was 0.7%. The attack rate of verruga peruana was 17.6%. A new specific immunostain was developed and used to confirm the presence of B. bacilliformis in the biopsied skin lesions. Most seropositive individuals (56%) were asymptomatic. The symptoms that were associated with prior infection, as determined by Western blot, included fever (37.2% of the seropositive vs. 17.2% of the seronegative population; P<.001), bone and joint pain (27% vs. 9%; P<.001), headache (27% vs. 12.3%; P <.001), and skin lesions described as verruga peruana (26.8% vs. 4.9%; P<.001). Our findings suggest that infection with B. bacilliformis causes a broad spectrum of disease that is significantly milder in severity than that frequently reported.
Asunto(s)
Infecciones por Bartonella/epidemiología , Adolescente , Adulto , Animales , Bartonella , Infecciones por Bartonella/patología , Niño , Escolaridad , Femenino , Humanos , Humedad , Masculino , Perú/epidemiología , Conejos , Piel/patología , TemperaturaRESUMEN
Two simple Bartonella bacilliformis immunoblot preparation methods were developed. Antigen was prepared by two different methods: sonication of whole organisms or glycine extraction. Both methods were then tested for sensitivity and specificity. Well-defined control sera were utilized in the development of these diagnostic immunoblots, and possible cross-reactions were thoroughly examined. Sera investigated for cross-reaction with these diagnostic antigens were drawn from patients with brucellosis, chlamydiosis, Q fever, and cat scratch disease, all of whom were from regions where bartonellosis is not endemic. While both immunoblots yielded reasonable sensitivity and high specificity, we recommend the use of the sonicated immunoblot, which has a higher sensitivity when used to detect acute disease and produces fewer cross-reactions. The sonicated immunoblot reported here is 94% sensitive to chronic bartonellosis and 70% sensitive to acute bartonellosis. In a healthy group, it is 100% specific. This immunoblot preparation requires a simple sonication protocol for the harvesting of B. bacilliformis antigens and is well suited for use in regions of endemicity.
Asunto(s)
Infecciones por Bartonella/diagnóstico , Bartonella/aislamiento & purificación , Immunoblotting/métodos , Bartonella/inmunología , Brucelosis/inmunología , Enfermedad por Rasguño de Gato/inmunología , Células Cultivadas , Infecciones por Chlamydia/inmunología , Reacciones Cruzadas , Electroforesis en Gel de Poliacrilamida , Glicina/química , Humanos , Fiebre Q/inmunología , Sonicación , Factores de TiempoRESUMEN
A 41-year-old male with a 25-year history of diabetes mellitus requiring 25 to 30 units of neutral protamine hagedorn (NPH) insulin daily was found dead at home. Recent history revealed that he was well until the last four days of life when he had the onset of nausea, vomiting, and anorexia coinciding with procurement of a new bottle of insulin from his pharmacist. Pertinent autopsy findings included coronary and aortic atherosclerosis, a peptic ulcer, and diabetic glomerulopathy. Chemical analysis of the vitreous humor, including glucose (813 mg/dL) and acetone (40 mg/dL), revealed that he died of diabetic ketoacidosis. Further investigation revealed that the pharmacist had accidentally substituted regular insulin, with a duration of action of up to 6 h as opposed to 24 to 28 h, for NPH. Cultures of blood and of the regular insulin yielded no growth. Analysis of this case emphasizes the importance of obtaining a careful medical and medication history and the usefulness of vitreous electrolytes when investigating a sudden death in a diabetic.